Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Panacea Biotec Ltd. ('PBL') is delighted to announce the landmark collaboration with Refana Inc. USA for Covid-19 vaccine which will enable global development, manufacturing and distribution of the Covid-19 vaccine. Under the collaboration, Panacea Biotec is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc. USA to make Covid-19 vaccine widely accessible around the world in an equitable manner through a Joint Venture company to be based in Ireland. A copy of the Press Release titled 'Panacea Biotec and Refana announce landmark collaboration for Covid-19 vaccine' being issued to the media, etc. in this regard is enclosed for your kind reference and record please.
10-06-2020
Bigul

Panacea Infosec to hike headcount by 40-45 per cent; sees rising demand for cybersecurity, audits

 At present, Panacea offers its services in verticals of cybersecurity consulting, auditing and compliance areas like certification and assessment services, CERT-In security auditing services, threat and vulnerability management, advisory services, managed security services, training and products.
09-06-2020
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith details of shares dematerialized during May, 2020 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
05-06-2020
Bigul

PANACEA BIOTEC LTD. - 531349 - Statement Of Investor Complaints For The Quarter Ended March 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Vinod GoelDesignation :- Company Secretary and Compliance Officer
13-05-2020
Bigul

PANACEA BIOTEC LTD. - 531349 - Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half-Year Ended March 31, 2020

 Pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certified copy of certificate from M/s. R & D, Company Secretaries, for the half-year ended March 31, 2020, confirming that all the transfers of shares have been completed within the stipulated time. This is for your kind information and record please.
11-05-2020
Bigul

PANACEA BIOTEC LTD. - 531349 - Shareholding for the Period Ended March 31, 2020

 Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
08-05-2020
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith details of shares dematerialised during the month of April, 2020
07-05-2020
Bigul

PANACEA BIOTEC LTD. - 531349 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Panacea Biotec Ltd has submitted to BSE a copy of Clarification is enclosed.
30-04-2020
Bigul

PANACEA BIOTEC LTD. - 531349 - Clarification sought from Panacea Biotec Ltd

 The Exchange has sought clarification from Panacea Biotec Ltd on April 29, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
29-04-2020
Bigul

PANACEA BIOTEC LTD. - 531349 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Panacea Biotec Ltd has submitted to BSE a copy of Clarification is enclosed.
13-04-2020
Next Page
Close

Let's Open Free Demat Account